J Figoni, C Chirouze, Y Hansmann, C Lemogne, V Hentgen, A Saunier, K Bouiller, J F Gehanno, C Rabaud, S Perrot, E Caumes, C Eldin, T de Broucker, B Jaulhac, F Roblot, J Toubiana, F Sellal, F Vuillemet, C Sordet, B Fantin, G Lina, X Gocko, M Dieudonné, B Bodaghi, J P Gangneux, B Degeilh, H Partouche, C Lenormand, A Sotto, A Raffetin, J J Monsuez, C Michel, N Boulanger, P Cathebras, P Tattevin
Lyme borreliosis is transmitted en France by the tick Ixodes ricinus, endemic in metropolitan France. In the absence of vaccine licensed for use in humans, primary prevention mostly relies on mechanical protection (clothes covering most parts of the body) that may be completed by chemical protection (repulsives). Secondary prevention relies on early detection of ticks after exposure, and mechanical extraction. There is currently no situation in France when prophylactic antibiotics would be recommended. The incidence of Lyme borreliosis in France, estimated through a network of general practitioners (réseau Sentinelles), and nationwide coding system for hospital stays, has not significantly changed between 2009 and 2017, with a mean incidence estimated at 53 cases/100,000 inhabitants/year, leading to 1...
May 13, 2019: Médecine et Maladies Infectieuses